At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BK4583 Monkeypox Concept
Trading 02-25 12:59:06 EST
2,031.87
-2.78
-0.14%
High2,055.90Low2,022.79Vol8.79M
Open2,034.75D1 Closing2,034.66Amplitude1.63%
Mkt Cap0.00Tradable Cap0.00Total Shares0.00
T/O527.00MT/O Rate--Tradable Shares0.00
P/B4.962837ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

BUZZ-U.S. STOCKS ON THE MOVE-Sharps Technology, Whirlpool, Applovin
Reuters  ·  02-25 23:46
BUZZ-U.S. STOCKS ON THE MOVE-Sharps Technology, Whirlpool, Applovin
Quest Diagnostics CFO Sam Samad to Speak at Leerink 2026 Global Healthcare Conference
Reuters  ·  02-25 23:00
Quest Diagnostics CFO Sam Samad to Speak at Leerink 2026 Global Healthcare Conference
BUZZ-Viatris rises as FDA begins review of eye drop for age‑related near‑vision loss
Reuters  ·  02-25 20:24
BUZZ-Viatris rises as FDA begins review of eye drop for age‑related near‑vision loss
Tonix Pharmaceuticals to Participate in TD Cowen Annual Healthcare Conference and Barclays Annual Healthcare Conference
Reuters  ·  02-25 20:01
Tonix Pharmaceuticals to Participate in TD Cowen Annual Healthcare Conference and Barclays Annual Healthcare Conference
FDA accepts Opus Genetics sNDA for phentolamine ophthalmic solution 0.75% to treat presbyopia
Reuters  ·  02-25 19:59
FDA accepts Opus Genetics sNDA for phentolamine ophthalmic solution 0.75% to treat presbyopia
FDA accepts Viatris sNDA for MR-141 presbyopia treatment review
Reuters  ·  02-25 19:59
FDA accepts Viatris sNDA for MR-141 presbyopia treatment review
Gilead: Strategic Arcellx Acquisition and Anito-cel Pipeline Strength Underpin Buy Rating and $162 Target
TIPRANKS  ·  02-25 18:06
Gilead: Strategic Arcellx Acquisition and Anito-cel Pipeline Strength Underpin Buy Rating and $162 Target
Class Action Lawsuit Targets Inovio Pharmaceuticals
Reuters  ·  02-25 06:58
Class Action Lawsuit Targets Inovio Pharmaceuticals
Gilead Sciences Inc. Stock Underperforms Tuesday When Compared To Competitors
Dow Jones  ·  02-25 05:35
Gilead Sciences Inc. Stock Underperforms Tuesday When Compared To Competitors
Gilead FY 2025 net income attributable to shareholders hits USD 8.5 billion (NM)
Reuters  ·  02-25 05:26
Gilead FY 2025 net income attributable to shareholders hits USD 8.5 billion (NM)
RPT-BREAKINGVIEWS-An $8 bln pharma deal prices patent fears
Reuters  ·  02-24 21:00
RPT-BREAKINGVIEWS-An $8 bln pharma deal prices patent fears
Gilead Sciences (GILD) Receives a Buy from Scotiabank
TIPRANKS  ·  02-24 19:36
Gilead Sciences (GILD) Receives a Buy from Scotiabank
COLUMN-Novartis quietly settles Henrietta Lacks suit as family’s legal push gains steam
Reuters  ·  02-24 09:32
COLUMN-Novartis quietly settles Henrietta Lacks suit as family’s legal push gains steam
Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
Dow Jones  ·  02-24 06:26
Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
CORRECTED-Belgium's Galapagos 2025 net revenue surges, driven by Gilead collaboration
Reuters  ·  02-24 05:12
CORRECTED-Belgium's Galapagos 2025 net revenue surges, driven by Gilead collaboration
Inovio Shareholders Face April 7 Deadline in Securities Fraud Class Action
Reuters  ·  02-24 02:07
Inovio Shareholders Face April 7 Deadline in Securities Fraud Class Action
FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms
Reuters  ·  02-24 01:09
FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms
Arcellx Stock (ACLX) Rockets on a Massive Deal with Gilead Sciences (GILD)
TIPRANKS  ·  02-24 01:03
Arcellx Stock (ACLX) Rockets on a Massive Deal with Gilead Sciences (GILD)
Arcellx downgraded to Hold from Buy at Needham
TIPRANKS  ·  02-23 23:40
Arcellx downgraded to Hold from Buy at Needham
Arcellx downgraded to Market Perform from Outperform at William Blair
TIPRANKS  ·  02-23 22:50
Arcellx downgraded to Market Perform from Outperform at William Blair

Introduction

Company Name.
BK4583
Affiliated Markets:
Listing Date:
--
Main Business:
Issue price:
--